참고문헌 (45)

1. Clin. Canc. Res. Al Moustafa 5 681 1999 Up-regulation of E-cadherin by an anti-epidermal growth factor receptor monoclonal antibody in lung cancer cell lines 

2. Exp. Cell Res. Alexandrova 312 2066 2006 10.1016/j.yexcr.2006.03.004 ROS up-regulation mediates Ras-induced changes of cell morphology and motility 

   상세보기

3. Invest. N. Drugs Ayoub 39 77 2021 10.1007/s10637-020-00989-0 Crizotinib induced antitumor activity and synergized with chemotherapy and hormonal drugs in breast cancer cells via downregulating MET and estrogen receptor levels 

   상세보기

4. J. Clin. Oncol. Bergethon 30 863 2012 10.1200/JCO.2011.35.6345 ROS1 rearrangements define a unique molecular class of lung cancers 

   상세보기

5. BMC Canc. Brandhagen 13 35 2013 10.1186/1471-2407-13-35 Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics 

   상세보기

6. Curr. Opin. Cell Biol. Brieher 25 39 2013 10.1016/j.ceb.2012.10.010 Cadherin junctions and their cytoskeleton(s) 

   상세보기

7. J. Cell Sci. Canel 126 393 2013 10.1242/jcs.100115 E-cadherin-integrin crosstalk in cancer invasion and metastasis 

   상세보기

8. Stem Cell. Dev. Carey 23 2921 2014 10.1089/scd.2014.0092 AMPK knockdown in placental trophoblast cells results in altered morphology and function 

   상세보기

9. OncoTargets Ther. Chang 10 3289 2017 10.2147/OTT.S138123 Reactive oxygen species mediate soft corals-derived sinuleptolide-induced antiproliferation and DNA damage in oral cancer cells 

   상세보기

10. BMC Canc. Chen 14 552 2014 10.1186/1471-2407-14-552 E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition 

    상세보기

11. Eur. J. Cell Biol. Chen 78 824 1999 10.1016/S0171-9335(99)80033-8 Proliferation arrest and induction of CDK inhibitors p21 and p27 by depleting the calcium store in cultured C6 glioma cells 

    상세보기

12. Mol. Canc. Therapeut. Christensen 6 3314 2007 10.1158/1535-7163.MCT-07-0365 Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma 

    상세보기

13. J. Med. Chem. Cui 54 6342 2011 10.1021/jm2007613 Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK) 

    상세보기

14. J. Exp. Clin. Cancer Res. Dai 36 120 2017 10.1186/s13046-017-0584-3 (S)-crizotinib induces apoptosis in human non-small cell lung cancer cells by activating ROS independent of MTH1 

    상세보기

15. Nat. Rev. Canc. de The 18 117 2018 10.1038/nrc.2017.103 Differentiation therapy revisited 

    상세보기

16. Oncogene Dirks 15 2037 1997 10.1038/sj.onc.1201392 Retinoic acid and the cyclin dependent kinase inhibitors synergistically alter proliferation and morphology of U343 astrocytoma cells 

    상세보기

17. Cell Death Dis. Enane 9 912 2018 10.1038/s41419-018-0919-9 Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells 

    상세보기

18. J. Thorac. Oncol. Fang 9 285 2014 10.1097/JTO.0000000000000087 HIP1-ALK, a novel ALK fusion variant that responds to crizotinib 

    상세보기

19. Mol. Cell. Garcia 66 789 2017 10.1016/j.molcel.2017.05.032 AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance 

    상세보기

20. Nature Huber 508 222 2014 10.1038/nature13194 Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy 

    상세보기

21. Canc. Cell Ishimoto 19 387 2011 10.1016/j.ccr.2011.01.038 CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth 

    상세보기

22. J. Clin. Invest. Ito 131 2021 10.1172/JCI141529 Stabilization of fatty acid synthesis enzyme acetyl-CoA carboxylase 1 suppresses acute myeloid leukemia development 

    상세보기

23. Cell Death Dis. Ji 9 660 2018 10.1038/s41419-018-0667-x (S)-crizotinib reduces gastric cancer growth through oxidative DNA damage and triggers pro-survival akt signal 

    상세보기

24. Stem Cell Res. Ju 12 86 2014 10.1016/j.scr.2013.09.011 Maintenance of the stemness in CD44(+) HCT-15 and HCT-116 human colon cancer cells requires miR-203 suppression 

    상세보기

25. Oncol Lett Jung 13 4925 2017 10.3892/ol.2017.6037 Monoclonal antibodies against autocrine motility factor suppress gastric cancer 

    상세보기

26. Oncol. Rep. Kang 27 1407 2012 Widdrol induces apoptosis via activation of AMP-activated protein kinase in colon cancer cells 

27. Case Rep Oncol Med 2020 Khalil 2020 Inflammatory myofibroblastic tumor: a rare presentation and an effective treatment with crizotinib 

28. OncoImmunology Koh 5 2016 10.1080/2162402X.2015.1108514 EML4-ALK enhances programmed cell death-ligand 1 expression in pulmonary adenocarcinoma via hypoxia-inducible factor (HIF)-1alpha and STAT3 

    상세보기

29. Prostate Lee 79 720 2019 10.1002/pros.23779 Dopamine receptor antagonists induce differentiation of PC-3 human prostate cancer cell-derived cancer stem cell-like cells 

    상세보기

30. PloS One Leung 5 2010 10.1371/journal.pone.0014062 Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties 

    상세보기

31. OncoImmunology Liu 8 2019 10.1080/2162402X.2019.1596652 Crizotinib - a tyrosine kinase inhibitor that stimulates immunogenic cell death 

    상세보기

32. Nat. Commun. Liu 10 1486 2019 10.1038/s41467-019-09415-3 Crizotinib-induced immunogenic cell death in non-small cell lung cancer 

    상세보기

33. J. Biol. Chem. Molina-Ortiz 284 15147 2009 10.1074/jbc.M807834200 Overexpression of E-cadherin on melanoma cells inhibits chemokine-promoted invasion involving p190RhoGAP/p120ctn-dependent inactivation of RhoA 

    상세보기

34. Clin. Canc. Res. Noh 24 4162 2018 10.1158/1078-0432.CCR-17-3492 Integrin beta3 inhibition enhances the antitumor activity of ALK inhibitor in ALK-rearranged NSCLC 

    상세보기

35. Nature Padmanaban 573 439 2019 10.1038/s41586-019-1526-3 E-cadherin is required for metastasis in multiple models of breast cancer 

    상세보기

36. Oncol. Patel 25 562 2020 10.1634/theoncologist.2020-0034 Phase Ib study of crizotinib plus pembrolizumab in patients with previously untreated advanced non-small cell lung cancer with ALK translocation 

    상세보기

37. Cell Metabol. Rios Garcia 26 842 2017 10.1016/j.cmet.2017.09.018 Acetyl-CoA carboxylase 1-dependent protein acetylation controls breast cancer metastasis and recurrence 

    상세보기

38. J Natl Canc. Inst Skehan 82 1107 1990 10.1093/jnci/82.13.1107 New colorimetric cytotoxicity assay for anticancer-drug screening 

    상세보기

39. Int. J. Oncol. Srinual 50 1341 2017 10.3892/ijo.2017.3879 Suppression of cancer stem-like phenotypes in NCI-H460 lung cancer cells by vanillin through an Akt-dependent pathway 

    상세보기

40. Proc. Natl. Acad. Sci. U. S. A. Suzuki 95 10499 1998 10.1073/pnas.95.18.10499 Farnesyltransferase inhibitors induce dramatic morphological changes of KNRK cells that are blocked by microtubule interfering agents 

    상세보기

41. Clin. Canc. Res. Tripathi 26 6122 2020 10.1158/1078-0432.CCR-20-2306 Dual blockade of c-MET and the androgen receptor in metastatic castration-resistant prostate cancer: a Phase I study of concurrent enzalutamide and crizotinib 

    상세보기

42. Curr. Cancer Drug Targets Wang 13 963 2013 10.2174/15680096113136660102 The role of Snail in EMT and tumorigenesis 

    상세보기

43. Lung Canc. Wang 146 165 2020 10.1016/j.lungcan.2020.06.003 The clinical efficacy of combinatorial therapy of EGFR-TKI and crizotinib in overcoming MET amplification-mediated resistance from prior EGFR-TKI therapy 

    상세보기

44. Curr. Mol. Med. Wang 16 232 2016 10.2174/1566524016666160225151408 HDAC inhibitor oxamflatin induces morphological changes and has strong cytostatic effects in ovarian cancer cell lines 

    상세보기

45. Chem. Biol. Drug Des. Zhang 78 999 2011 10.1111/j.1747-0285.2011.01239.x Crizotinib-resistant mutants of EML4-ALK identified through an accelerated mutagenesis screen 

    상세보기

활용도 Top5 논문

더보기

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.